What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Merits of percentage hypochromic red cells as a marker of functional iron deficiency

被引：43

作者：

Macdougall, IC ^{[1
]}

机构：

[1] Univ London Kings Coll Hosp, Dept Renal Med, London SE22 8PT, England

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 04期

关键词：

D O I：

10.1093/ndt/13.4.847

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：847 / 849

页数：3

共 25 条

[1] SERUM FERRITIN ASSAY AND BONE-MARROW IRON STORES IN PATIENTS ON MAINTENANCE HEMODIALYSIS [J].

BELL, JD ;

KINCAID, WR ;

MORGAN, RG ;

BUNCE, H ;

ALPERIN, JB ;

SARLES, HE ;

REMMERS, AR .

KIDNEY INTERNATIONAL, 1980, 17 (02) :237-241

[2]

BIRGEGARD G, 1978, SCAND J HAEMATOL, V21, P333

[3] SERUM FERRITIN AND BONE-MARROW IRON IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

BLUMBERG, AB ;

MARTI, HRM ;

GRABER, CG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (24) :3317-3319

[4] Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients [J].

Braun, J ;

Lindner, K ;

Schreiber, M ;

Heidler, RA ;

Horl, WH .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (06) :1173-1181

[5] MEMBRANE-PROPERTIES OF ERYTHROCYTES IN SUBJECTS UNDERGOING MULTIPLE BLOOD DONATIONS WITH OR WITHOUT RECOMBINANT ERYTHROPOIETIN [J].

BRUGNARA, C ;

KRUSKALL, MS ;

JOHNSTONE, RM .

BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (01) :118-130

[6] HYDRATION OF RED-CELLS IN ALPHA-THALASSEMIA AND BETA-THALASSEMIA DIFFERS - A USEFUL APPROACH TO DISTINGUISH BETWEEN THESE RED-CELL PHENOTYPES [J].

BUNYARATVEJ, A ;

FUCHAROEN, S ;

GREENBAUM, A ;

MOHANDAS, N .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (02) :217-222

[7]

Bunyaratvej Ahnond, 1992, Journal of the Medical Association of Thailand, V75, P248

[8]

CAVILL I, 1982, CLIN HAEMATOL, V11, P259

[9]

DONOFRIO G, 1992, ARCH PATHOL LAB MED, V116, P84

[10] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

← 1 2 3 →